Carbidopa And Levodopa Tablet
Product Images NDC 0904-7549

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0904-7549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25mg/100mg Carton Label (3f6d393e Ac84 4a3c A837 199d1ec71fd2 00)

This is a single packaging of Major brand Carbidopa and Levodopa tablets, each containing 25 mg of Carbidopa and 100 mg of Levodopa. The package consists of 100 tablets in total, divided into 10 blister packs of 10 tablets each. The tablets are intended for prescription use only and are specifically designed for unit dose administration. The product is recommended to be stored in tight, light-resistant containers to maintain its efficacy. The tablets are formulated for an extended-release effect and are intended for the treatment of certain conditions related to dopamine deficiency.*

FDA Label Image

Chemical-structure (Carbilevo 01)

FDA Label Image

Chemical-structure (Carbilevo 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.